Skip to main content
. 2023 Jul 18;12(14):4741. doi: 10.3390/jcm12144741

Figure 4.

Figure 4

Levels of S-RBD IgG in SAID patients treated with IL-1i. (A). S-RBD IgG levels were measured in COVID− HC and COVID− SAID patients treated with IL-1i at T3, T6, and T9. Data are reported as median and IQR. p was calculated according to Kruskal-Wallis’s test. Dunn post hoc test, **** p < 0.0001, *** p < 0.001. (B). S-RBD IgG levels in SAID patients treated or not with IL-1i were measured at T3, T6, and T9. Data are reported as mean ± SEM. p was calculated according to Kruskal-Wallis’s test. Dunn post hoc test, ** p < 0.005, **** p < 0.0001. HC, healthy controls; SAID, Systemic autoinflammatory diseases; IL-1i, interleukin 1 inhibitors, IQR, interquartile range.